Oncolytic adenovirus-mediated p53 gene therapy using OBP-702 showed cytotoxic effects for both gastric cancer cells and CAFs but did not affect the viability of normal cells via wild-type p53 replication. The gene discussed is TP53; the disease is gastric cancer.